Okyo Pharma Share Discussion Threads

[p5tvr] 25/2/2021 15:08

Andre i see that (How to understand charts to improve your chances to make money from the market) course you went on was worth it, how much are you down now?....LOL

[p5tvr] 25/2/2021 09:02

LOL...LOSER!.

[andre] 25/2/2021 09:00

Have a lovely day.

[andre] 25/2/2021 08:03

It must be better than your attention span though.

[p5tvr] 24/2/2021 11:52

Andre...I think your chart skills SUCK!!!!

[andre] 21/2/2021 21:40

More than happy to. A good stock in a diversified portfolio.

[andre] 21/2/2021 08:19

More not jord. Spellcheck.

[andre] 21/2/2021 08:18

I don't know when. But they have filed a patent for the use of Chemerin for anti-inflammatory treatment for Covid. This is after it showed that it worked to reduce inflammation and pain in mice. Chemerin was initially meant to treat dry eyes and inflammation which is a massive market in itself. Opioid treatment of chronic pain is hugely problematic. It creates dependency which isn't much better than the pan overall. Especially as the body gets used to increasing doses of opioids for the same amount of pain. Meaning jord is constantly needed. Chemerin could be another solution and if so that market is massive also.These companies get bought for their patents. Add that to the chart and I'm happy to be a long term holder.

[wd1010] 19/2/2021 22:05

When do you expect to start hearing news?

[andre] 19/2/2021 20:16

This isn't a punters stock. It's a value buy. I'm not expecting fireworks until news.

[p5tvr] 19/2/2021 12:07

Well let's see if it can sustain a rise this time of more than half a penny....LOL

[andre] 19/2/2021 11:29

It still says the same. Perhaps you should do a bit of studying.

[andre] 16/2/2021 07:39

The chart still says buy. Did you go to school? You don't have to be up yet. It's half term you know.

[andre] 09/2/2021 09:18

It seems to be being bought in large chunks atm. 6.5% up as I write. The chart was an obvious buy yesterday.

[andre] 08/2/2021 12:44

Check the chart. Here we go.

[p5tvr] 21/1/2021 11:02

Wd..I see that your pump is having the opposite effect,if you're trying to get your losses back you really should try harder...LOL

[wd1010] 21/1/2021 08:48

Price target next few months? I've been holding this for many months as can see huge potential. Current pipeline...First is is the potential treatment for dry eye conditions, known as OK-113. Based on pre-clinical tests, the company believes its candidate could prove superior to the current leading dry-eye product in the market, Allergan's Restatis, which generates annual sales of US$1.2bn.A second asset on OKYO's books is a potential non-opioid pain relief product. This again is a huge market. Third is the latest development "OKYO announces filing of a patent application covering the use of Chemerin and associated analogues to treat "cytokine storm" associated with COVID-19 and ARDS

[stenick] 19/1/2021 17:22

God that was a damp squibb !

[chris2020] 19/1/2021 07:11

RNS released re patent application for chemerin as treatment for COVID-related effects.

[chris2020] 15/1/2021 09:56

Up c. 50 per cent since the betaville article